A phase 1 study of ADI-PEG 20 and modified FOLFOX6 in patients with advanced hepatocellular carcinoma and other gastrointestinal malignancies.
Cancer Chemotherapy and Pharmacology.
Times cited: 4
Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers.
Seminars in Oncology.
Times cited: 2